Zoetis | ZTS - Gross Profit On Sales



Zoetis reported $1.78B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
AbbVie USD 9.34B 1.36B Mar/2025
Align Technology USD 708.12M 28.01M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Charles River Laboratories USD 291.68M 48.42M Jun/2025
Dentsply International USD 490M 24M Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Henry Schein USD 952M 48M Jun/2025
Idexx Laboratories USD 694.73M 71.35M Jun/2025
Illumina USD 695M 12M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
J&J USD 14.6B 816M Mar/2025
Laboratory Of America USD 1.05B 98.2M Jun/2025
Merck USD 12.99B 224M Jun/2025
Neogen USD 92.85M 17.41M May/2025
Pacira USD 125.91M 8.71M Jun/2025
Perrigo USD 362.9M 29.4M Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Quest Diagnostics USD 904M 35M Jun/2025
Sanofi EUR 7.74B 26M Jun/2025
Sanofi EUR 7.74B 2.38B Jun/2025
Zoetis USD 1.78B 180M Jun/2025